Publications by authors named "Mark A Wolf"

Claim this Profile
D
Discovery of ONO-TR-772 (VU6018042): A Highly Selective and CNS Penetrant TREK Inhibitor Tool Compound.
Motoyuki Tanaka, Takahiro Mori, Gakuji Hashimoto, Katsukuni Mitsui, Akihiro Kishi, Mark A Wolf

ACS Med Chem Lett· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endovascular Fiducial Placement in Splenic Metastatic Disease as a Novel Option for Radiotherapy: A Case Report.
Adriana C Timmers, Joost Nuyttens, Mark A de Wolf

Cureus· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.
Heather A Ogana, Samantha Hurwitz, Chih-Lin Hsieh, Huimin Geng, Markus Müschen, Mark A Wolf

Front Cell Dev Biol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of flexibility versus radial force in rigid versus more flexible venous stents?
Timme Maj van Vuuren, Mark Af de Wolf, Cees Ha Wittens

Phlebology· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stent extension into a single inflow vessel is a valuable option after endophlebectomy.
Timme Maj van Vuuren, Ralph Lm Kurstjens, Mark Af de Wolf, Jorinde Hh van Laanen, Cees Ha Wittens

Phlebology· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The inability of venous occlusion air plethysmography to identify patients who will benefit from stenting of deep venous obstruction.
Ralph Lm Kurstjens, Fabio S Catarinella, Yee Lai Lam, Mark Af de Wolf, Irwin M Toonder

Phlebology· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors of postthrombotic syndrome before and after deep venous thrombosis treatment.
Rob Hw Strijkers, Mark Af de Wolf, Cees Ha Wittens

Phlebology· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abdominal and pubic collateral veins as indicators of deep venous obstruction.
Ralph L M Kurstjens, Timme M A J van Vuuren, Mark A F de Wolf, Rick de Graaf, Carsten W K P Arnoldussen

J Vasc Surg Venous Lymphat Disord· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply.
Ralph L M Kurstjens, Mark A F de Wolf, Rob H W Strijkers, Carsten W K P Arnoldussen, Irwin M Toonder

J Vasc Surg Venous Lymphat Disord· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Biological Evaluation of N-((1-(4-(Sulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide Inhibitors of Glycine Transporter-1.
Christopher L Cioffi, Shuang Liu, Mark A Wolf, Peter R Guzzo, Kashinath Sadalapure

J Med Chem· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The value of hemodynamic measurements by air plethysmography in diagnosing venous obstruction of the lower limb.
Ralph L M Kurstjens, Mark A F de Wolf, Sarah A Alsadah, Carsten W K P Arnoldussen, Rob H W Strijkers

J Vasc Surg Venous Lymphat Disord· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Theme 4: Invasive management of (recurrent) VTE and PTS.
Anthony J Comerota, Per Morten Sandset, Stavros Konstantinides, Rick de Graaf, Thomas W Wakefield, Mark A F de Wolf

Thromb Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and SAR of N-((1-(4-(propylsulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide inhibitors of glycine transporter-1.
Christopher L Cioffi, Mark A Wolf, Peter R Guzzo, Kashinath Sadalapure, Visweswaran Parthasarathy

Bioorg Med Chem Lett· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.
Anthony D Pechulis, James P Beck, Matt A Curry, Mark A Wolf, Arthur E Harms

Bioorg Med Chem Lett· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-Functionalized indazoles as glucocorticoid receptor agonists.
Mei Bai, Grant Carr, Russell J Deorazio, Thomas D Friedrich, Svetlana Dobritsa, Mark A Wolf

Bioorg Med Chem Lett· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of benzoazepinone-derived cyclic malonamides and aminoamides as potent gamma-secretase inhibitors.
Michael G Yang, Jian-Liang Shi, Dilip P Modi, Jennifer Wells, Brian M Cochran, Mark A Wolf

Bioorg Med Chem Lett· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic Routes to Allenic Acids and Esters and Their Stereospecific Conversion to Butenolides.
James A. Marshall, Mark A. Wolf, Eli M. Wallace

J Org Chem· January 1997

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis